Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REG1 vs Heparin in Elective PCI
NCT00715455Phase 2Completed
- Sponsor
- Regado Biosciences
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 2
01
Overview
A Phase 2 trial of pegnivacogin in coronary artery disease (CAD), sponsored by Regado Biosciences. Started Oct 2007; status: completed.
02
Drugs
pegnivacogin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00715455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715455.